Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Third Dose Moderna Vaccine in Transplant Recipients
NCT04885907Phase 4Completed
- Sponsor
- University Health Network
- Start
- May 2021
- Primary completion
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by University Health Network. Started May 2021; status: completed.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04885907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04885907.